An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months. [electronic resource]
Producer: 20110419Description: 242-50 p. digitalISSN:- 0301-0430
- Aged
- Anemia -- blood
- Australia
- Biomarkers -- blood
- Darbepoetin alfa
- Drug Administration Schedule
- Erythropoietin -- administration & dosage
- Europe
- Female
- Hematinics -- administration & dosage
- Hemoglobins -- metabolism
- Hospitalization
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Peritoneal Dialysis -- adverse effects
- Prospective Studies
- Renal Dialysis -- adverse effects
- Retrospective Studies
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.